HIGHLIGHTS
- who: Igor Radanovic from the Xiangya Hospital, Central South University, China have published the Article: Integration of healthy volunteers in early phase clinical trials with immuno-oncological compounds, in the Journal: (JOURNAL) of 20/Oct/2020
- what: Frontiers in Oncology Data extraction Relevant data were extracted from the included studies, including treatment, target, study design, study objectives, pharmacodynamic endpoints, number of enrolled subjects, frontiersin.org 10.3389/fonc.2022.954806
- how: For (certain members of) the new class of targeted immunotherapies pharmacological activity can be evaluated in HVs . An overview of the safety . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.